| pubmed-article:8635020 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0221102 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0023413 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C2931822 | lld:lifeskim |
| pubmed-article:8635020 | lifeskim:mentions | umls-concept:C0086960 | lld:lifeskim |
| pubmed-article:8635020 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:8635020 | pubmed:dateCreated | 1996-7-8 | lld:pubmed |
| pubmed-article:8635020 | pubmed:abstractText | Cisplatin, 5-flourouracil (5-FU), and leucovorin (PFL) chemotherapy has been reported to be effective in the treatment of cancers but severe mucositis or neutropenia are dose limiting toxicities. This Phase II study evaluated the anticancer effect and the toxicities of a new weekly 24-hour infusional PFL chemotherapy in patients with nasopharyngeal carcinoma (NPC). | lld:pubmed |
| pubmed-article:8635020 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8635020 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8635020 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8635020 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8635020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8635020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8635020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8635020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8635020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8635020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8635020 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8635020 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:8635020 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:8635020 | pubmed:author | pubmed-author:RaoL MLM | lld:pubmed |
| pubmed-article:8635020 | pubmed:author | pubmed-author:ChenS YSY | lld:pubmed |
| pubmed-article:8635020 | pubmed:author | pubmed-author:ChenK YKY | lld:pubmed |
| pubmed-article:8635020 | pubmed:author | pubmed-author:ChanW KWK | lld:pubmed |
| pubmed-article:8635020 | pubmed:author | pubmed-author:ShuC HCH | lld:pubmed |
| pubmed-article:8635020 | pubmed:author | pubmed-author:ChoK RKR | lld:pubmed |
| pubmed-article:8635020 | pubmed:author | pubmed-author:LawC KCK | lld:pubmed |
| pubmed-article:8635020 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8635020 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:8635020 | pubmed:volume | 76 | lld:pubmed |
| pubmed-article:8635020 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8635020 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8635020 | pubmed:pagination | 2186-92 | lld:pubmed |
| pubmed-article:8635020 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:meshHeading | pubmed-meshheading:8635020-... | lld:pubmed |
| pubmed-article:8635020 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8635020 | pubmed:articleTitle | Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma. | lld:pubmed |
| pubmed-article:8635020 | pubmed:affiliation | Cancer Therapy Center, Veterans General Hospital-Taipei, Taiwan, Taipei, Republic of China. | lld:pubmed |
| pubmed-article:8635020 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8635020 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8635020 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:8635020 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8635020 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8635020 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8635020 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8635020 | lld:pubmed |
